Acute Kidney Injury in the NICU Patient

David Askenazi MD, MSPH was born in Mexico City and grew up in El Paso, Texas. He attended the University of Texas at Austin where he received a Bachelor of Arts in Psychology. He received his medical degree from the University of Texas Medical Branch at Galveston. He completed pediatric residency training at the Austin Pediatric Education Program, followed by a fellowship in Pediatric Nephrology at Baylor College of Medicine / Texas Children’s Hospital. He completed a Master of Science in Clinical Research at the University of Alabama at Birmingham (UAB). 

Dr Askenazi joined the faculty in the Department of Pediatrics at UAB as an Assistant Professor in 2005 and was promoted to Full Professor in 2016. He was appointed the inaugural W. Charles Mayer Endowed Chair of Pediatric Nephrology in 2021. He founded and is currently the Medical Director of the Pediatric and Infant Center for Acute Care Nephrology (PICAN) at Children’s of Alabama / UAB. As Medical Director, he oversees the acute renal replacement therapies, plasmapheresis, peritoneal dialysis, and photopheresis programs. 

Dr Askenazi has received numerous research and education grants from industry, FDA, NIH, and nonprofit foundations. He has published original manuscripts on multiple topics, primarily related to understanding and improving outcomes in hospitalized neonates and children with and at-risk for kidney disease. He has written multiple invited reviews and chapters and is regularly invited to speak at national and international meetings. He founded and currently serves as the Board Chair of the Neonatal Kidney Collaborative (NKC) (www.babykidney.org). He founded and is the current Chief Scientific Officer for Zorro-Flow Inc.